Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-664-3 | CAS number: 67-68-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
DMSO is used world wide as a solvent for poorly water-soluble substances in the genotoxicity tests and it has beeen tested in a large number of assays using a wide range of methods.
In Vitro Studies – Gene Mutations Assays
In a study performed with a method comparable to the OECD Guide-line no. 471, DMSO was tested in two separate laboratories in the gene mutations assay in bacteria. Concentrations of DMSO (100, 333, 1000, 3333, and 10,000 µg), overnight culture of Salmonella typhimurium strains TA97, TA98, TA100, TA1535, TA1537, and S-9 mix or buffer were incubated without shaking for 20 minutes. The top agar was added and the contents of the tubes were mixed and poured onto the surfaces of petri dishes. His+ (histidine dependent) colonies arising on plates were machine-counted after two days incubation. Initial testing was without metabolic activation, with 10% rat liver S-9, or with 10% hamster liver S-9. After a negative result was obtained, DMSO was retested without S-9 and with 30% S-9 from rat and hamster. Positive controls were sodium azide (TA 1535 and TA100), 9-aminoacridine or ICR-191 (TA 97 and TA1537) and 4-nitro-o-phenylenediamine (TA98) without S9 and 2-aminoanthracene (all strains) with S9: The positive control chemicals induced a significant increase of the revertant frequency in all tester strains, either with or without metabolic activation. DMSO was negative, in the presence and absence of metabolic activation, in all tester strains (Zeiger et al., 1992; NTP, 1987 & 1988).
In addition DMSO was not mutagenic in the Salmonella typhimurium strains TA97, TA98 and TA100 using the standard plate incorporation protocol, both in the presence and absence of metabolic activation (De Flora, 1981 and Brams et al., 1987).
In a study to test the compatibility of organic solvents with the Microscreen prophage-induction assay, DMSO was tested up to a concentration of 10% in the culture medium on Escherichia coli WP2s(l). (Dee Marini et al., 1991). DMSO was genotoxic in the presence and absence of S9.
No guideline compliant assay for gene mutations in mammalian cells is available for DMSO. Three tests performed only without metabolic activation are available, two L5178y/TK-/+ assays (Amacher et al., 1980 and Wangenheim et al., 1988) and one CHO/HGPRT assay (Amacher et al., 1984). At very high concentrations of DMSO (> 1 mmol/ml = 78 mg/ml), well in excess of the limit concentration recommended by the OECD guidelines (5 mg/ml), an increase of the mutation frequency was observed in one mouse lymphoma assay (Wangenheim et al., 1988), both 2 others assays were negative.
In Vitro Studies – Chromosomal aberrations Assays
In a study performed with a method comparable to the OECD Guide-line no. 473, DMSO was tested with Chinese hamster ovary (CHO) cells in culture at concentrations of 0, 499, 1500 and 4990 µg/ml, in the presence and absence of liver microsomal fraction (S9) from Aroclor 1254-induced male Sprague-Dawley rats, to determine its in vitro cytogenetic potential (Loveday et al., 1990). Medium control was used with each assay with or without S9. Mitomycin C was used in the experiments without metabolic activation, and cyclophosphamide was used in the experiments with activation as positive controls. The positive control chemicals induced a significant increase of the frequency of the chromosomal aberrations. DMSO did not induce cell toxicity or cell cycle delay, and did not induce an increase in the incidence of chromosomal aberrations.
In Saccharomyces cerevisiae, strain BR1669, DMSO failed to induce mitotic chromosome gain or arg4-8 reversion and had no effect on meiotic hyperploidy or reversion (Whittaker et al., 1990).
In Vitro Studies – other genotoxicity endpoints
DMSO was tested in CHO cells to a maximum concentration of 5000 µg/ml. DMSO did not induce cell toxicity or cell cycle delay, and did not induce an increase in the incidence of SCEs potential (Loveday et al., 1990).
DMSO did not increase the SOS-inducing activity when tested on Escherichia coli PQ37 (Brams et al., 1987).
In vivo studies
In an in vivo micronucleus assay performed according to the OECD guideline no. 474 and GLP, groups of 6 male and 6 female Han Wistar rats received 5 daily i.p. injections at the dose levels of 0, 200, 1000 and 5000 mg DMSO/kg bw/d. The animals were sacrificed 24 hours after the last dosing and bone marrow collected and evaluated for the presence of micronucleated polychromatic erythrocytes. The negative and positive controls in the study were purified water and cyclophosphamide, respectively. There was no increase in the incidence of micronuclei in the polychromatic erythrocytes of the bone marrow of male and female Han Wistar treated with DMSO as compared to concurrent controls (Marshall, 2002).
Additional in vivo studies - dominant lethal assay in mice (Chauhan et al., 1975), interchromosomal mitotic recombination, sex-linked recessive lethal mutations and sex chromosome loss assays in Drosophila melanogaster (Vogel and Nivard, 1993; Mollet et al., 1974), micronucleus assay in Pleurodeles waltl (Fernandez et al., 1993) and sister chromatid exchanges assay in mice (Sharma et al., 1985) - have resulted in uniformly negative results.
Short description of key information:
In studies performed with methods compliant to OECD guidelines, no genotoxic activity was observed for DMSO in gene mutations assays in Salmonella typhimurium, an in vitro cytogenetics assay in CHO cells and an in vivo micronucleus assay in rats. With few exceptions, a large battery of additional in vitro and in vivo non-guideline studies confirmed the lack of genotoxic potential.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the available data, no classification for mutagenicity has to be applied for DMSO according to EU Directive 67/584/EEC and EU regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
